Scientific Profile: SR9011 Powder – 1g (Advanced Rev-ErbA Agonist)
SR9011 represents a significant leap forward in the study of nuclear receptor subfamily 1 group D members (NR1D1). As a potent Rev-ErbAα/β agonist, SR9011 directly influences the circadian clock mechanism, regulating genes involved in glucose and fatty acid oxidation. Our SR9011 Powder – 1g is designed for researchers who require the ability to formulate custom-concentration solutions in vehicles like DMSO or PEG-400 for longitudinal analytical studies.
Technical Specifications & Data Accuracy
Reliable research begins with verified materials. We provide full batch-traceability for every gram of SR9011.
| Property | Specification |
| CAS Number | 1379686-29-9 |
| Molar Mass | 479.04 g/mol |
| Chemical Formula | $C_{23}H_{31}ClN_{4}O_{3}S$ |
| Purity | >99% (HPLC Verified) |
| Form | White to off-white crystalline powder |
| Storage | Store at -20°C for 3-year stability |
Synergistic Research: SR9011 and Chemyo MK 677
A primary focus in metabolic research is the “Homeostasis Axis”—the relationship between energy expenditure and tissue regeneration. Many advanced protocols utilize SR9011 Powder – 1g alongside a growth hormone secretagogue to observe these complex interactions.
By procuring your materials through our platform, you ensure that your Chemyo MK 677 and SR9011 are from the same high-standard manufacturing stream. This consistency is why researchers searching for MK 677 for sale prioritize our laboratory; we eliminate the purity variances that can compromise an entire year of data collection.
Why Our SR9011 Powder Leads the 2026 Market
To outrank the competition, we focus on the purity of the raw crystalline state. While other shops sell diluted solutions, our 1g powder offers the highest concentration of active material per dollar. This crystalline form is more resistant to environmental degradation and provides the analytical flexibility required for modern high-resolution experiments. When you choose our SR9011, you are investing in the gold standard of 2026 research ligands.













